Skip to main content

VIVIMEDLAB · Vivimed Labs Limited · Financials

5.40 INR -0.04 (-0.74%) At close · Nov 13
Volume · Nov 13 24.15K Avg daily vol (8 sessions) 6805

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
699.89M -39.8%
FY2026 Revenue FY2018–FY2026
Net Income
0
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
77.01M +171.2%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2018
INR 699.89M 1.16B 1.49B 1.87B 2.37B 8.61B 10.59B 11.86B
INR 260.52M 202.24M 199.41M 1.08B 182.82M 554.95M 669.46M 564.2M
INR 41.7M 29.47M 24.32M 359.03M 397.6M 538.76M 588.92M 794.83M
INR -1.75B -313.85M -458.23M -3.31B -648.33M -757.66M -1.09B 857.11M
INR 1.37M 1.13M -3.77M -21.17M 28.17M 20.29M -3.6M 96.21M
INR 0 0 0 -3.28B 0 -777.95M 0 779.42M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.